Type 2 Diabetes Trial, Recruiting NCT07659925 Sponsor: Baskent University Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, Recruiting

NCT07659925
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults between 18 and 65 years of age
  • People who have been diagnosed with Type 2 Diabetes
  • People who have not taken part in any regular, structured exercise program in the last 6 months
  • People who are willing to take part and sign a written consent form

Who may not be able to join:

  • People who have diabetes-related complications affecting the kidneys, eyes, or nerves in the feet and hands
  • People who have a neurological, cognitive, or bone and joint condition that could affect how results are measured
  • People with severe lung disease where breathing tests show significantly reduced lung function (confirm with trial site)
  • People who have a condition affecting blood flow to the heart or to the legs and feet
  • People who have had a heart attack, stroke, or other heart or blood vessel event in the last 6 months
  • People who currently have cancer

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Neslihan Duruturk, PhD, Baskent University

Phone: +90 553-301-36-73

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Baskent University
Registry
ClinicalTrials.gov
Start date
1 May 2026
Est. completion
1 November 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Exercise Capacity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov